Richard Ian Griffiths - 03 Aug 2025 Form 4 Insider Report for Silence Therapeutics plc (SLN)

Role
10%+ Owner
Signature
/s/ Richard Ian Griffiths
Issuer symbol
SLN
Transactions as of
03 Aug 2025
Net transactions value
$0
Form type
4
Filing time
13 Feb 2026, 06:02:01 UTC
Previous filing
04 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Griffiths Richard Ian 10%+ Owner 19-21 BROAD STREET, ST HELIER, JERSEY /s/ Richard Ian Griffiths 13 Feb 2026 0001846370

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLN American Depositary Shares Sale +20,000 +0.17% 11,805,861 03 Aug 2025 Ordinary Shares 60,000 $5.45 See footnote F1, F2
transaction SLN American Depositary Shares Purchase +20,000 +0.17% 11,825,861 03 Aug 2025 Ordinary Shares 60,000 $5.45 See footnote F1, F2
transaction SLN American Depositary Shares Sale +2,000 +0.02% 11,819,861 27 Oct 2025 Ordinary Shares 6,000 $7.75 See footnote F1, F2
transaction SLN American Depositary Shares Purchase +2,000 +0.02% 11,825,861 27 Oct 2025 Ordinary Shares 6,000 $7.75 See footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each American Depositary Share ("ADS") is immediately convertible into three ordinary shares for no consideration and has no expiration date.
F2 The securities were sold by Ora Capital Limited ("OCL") and purchased by Mr. Griffiths personally, essentially internal transfers with no change in total beneficial holding. Mr Griffiths is a director and the controlling shareholder of OCL. Mr. Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein.